Systems Analysis of Single-Cell Heterogeneity Underlying Glioma Drug Resistance
Demographics (1)
- SEX - Biological sex (phv00536193.v1.p1)
Disease Events (1)
- CASE_CONTROL_STATUS - Case control status of the subject for glioblastoma multiforme (phv00536197.v1.p1)
Other (20)
- ANALYTE_TYPE - Analyte type (phv00536202.v1.p1)
- BODY_SITE - Body site where tumor was collected from which samples were derived (phv00536201.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00536192.v1.p1)
- GSC_TREATMENT - Type of treatment for sample (phv00536209.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type (phv00536204.v1.p1)
- IDH1 - Somatic mutation in IDH1 (Entrez GeneID: 3417) (phv00536198.v1.p1)
- IS_TUMOR - Tumor status (phv00536203.v1.p1)
- MGMT - Methylation status of MGMT protein (Entrez GeneID: 4255) (phv00536199.v1.p1)
- PRIMARY_METASTATIC_TUMOR - Primary tumor, metastasis, or derived cell line (phv00536205.v1.p1)
- PRIMARY_TUMOR_LOCATION - Primary tumor location (phv00536206.v1.p1)
- REPLICATE - Sample replicate number (phv00536211.v1.p1)
- SAMPLE_ID - Sample ID (phv00536200.v1.p1)
- SAMPLE_ID - Sample ID (phv00536195.v1.p1)
- SAMPLE_TYPE - Type of sample used for analysis (phv00536697.v1.p1)
- SUBJECT_ID - Subject ID (phv00536196.v1.p1)
- SUBJECT_ID - Subject ID (phv00536191.v1.p1)
- SUBJECT_ID - Subject ID (phv00536194.v1.p1)
- TREATMENT_TIME - Treatment time for sample (phv00536210.v1.p1)
- TUMOR_GRADE - Tumor grade of sample (phv00536208.v1.p1)
- TUMOR_STAGE - Tumor stage of sample (phv00536207.v1.p1)